Healthcare & Life Sciences
Immune-Onc Therapeutics
United Statesimmune-onc.com
Immune-Onc Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Immune-Onc Therapeutics
Immune-Onc Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Immune-Onc Therapeutics develops clinical-stage biologic therapies that target myeloid cell surface proteins to treat blood cancers, solid tumors, and autoimmune diseases by modulating or depleting specific subsets of myeloid cells involved in disease.
Explore Immune-Onc Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.